PIK3CA and neoplasm: It exhibits potent anti-proliferative and anti-tumor activities in a variety of cancers including breast cancer, nasopharyngeal carcinoma and lung squamous cell carcinoma (LSCC) in a PIK3CA-dependent manner [76–78].